Alto Neuroscience Announces $50 Million Private Placement Financing

Core Insights - Alto Neuroscience, Inc. has announced a private placement financing agreement to raise approximately $50 million in gross proceeds [1] Company Summary - Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing novel precision medicines for neuropsychiatric disorders [1] - The financing involves institutional and accredited investors [1]